Apellis Pharmaceuticals Inc (APLS) ^Track

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Share on Twitter

Get access to advanced features

Subscribe to better monitor insider activity

Stock chart

Ticker: APLS Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
March 23, 2023	March 21, 2023	PS Planned sale	Francois Cedric Chief Executive Officer Executive Director	30,000 -2.6% 62.74 1,882,332 USD	30,000 -2.6%	62.74	1,882,332 USD
March 21, 2023	March 17, 2023	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 64.03 80,038 USD	1,250 -0.5%	64.03	80,038 USD
March 10, 2023	March 8, 2023	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 63.79 765,480 USD	12,000 -1.2%	63.79	765,480 USD
March 7, 2023	March 3, 2023	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -6.2% 63.84 319,200 USD	5,000 -6.2%	63.84	319,200 USD
March 2, 2023	March 1, 2023	PS Planned sale	Dunlop A. Sinclair Non-Executive Director	500 -0.4% 65.33 32,665 USD	500 -0.4%	65.33	32,665 USD
Feb. 27, 2023	Feb. 23, 2023	PS Planned sale	Lewis Karen Chief People Officer Officer	1,104 -2.6% 68.76 75,911 USD	1,104 -2.6%	68.76	75,911 USD
Feb. 27, 2023	Feb. 23, 2023	PS Planned sale	Eisele Jeffrey Chief Development Officer Officer	1,646 -3.0% 68.76 113,179 USD	1,646 -3.0%	68.76	113,179 USD
Feb. 21, 2023	Feb. 17, 2023	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 52.38 65,475 USD	1,250 -0.5%	52.38	65,475 USD
Feb. 10, 2023	Feb. 8, 2023	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 54.45 653,400 USD	12,000 -1.2%	54.45	653,400 USD
Feb. 6, 2023	Feb. 3, 2023	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -6.9% 55.85 279,250 USD	5,000 -6.9%	55.85	279,250 USD
Feb. 2, 2023	Feb. 1, 2023	PS Planned sale	Dunlop A. Sinclair Non-Executive Director	500 -0.4% 52.61 26,305 USD	500 -0.4%	52.61	26,305 USD
Jan. 31, 2023	Jan. 30, 2023	PS Planned sale	Lewis Karen Chief People Officer Officer	883 -2.4% 52.76 46,587 USD	883 -2.4%	52.76	46,587 USD
Jan. 31, 2023	Jan. 30, 2023	PS Planned sale	Eisele Jeffrey Chief Development Officer Officer	883 -1.9% 52.76 46,587 USD	883 -1.9%	52.76	46,587 USD
Jan. 25, 2023	Jan. 23, 2023	PS Planned sale	Lewis Karen Chief People Officer Officer	2,955 -7.3% 51.58 152,419 USD	2,955 -7.3%	51.58	152,419 USD
Jan. 25, 2023	Jan. 23, 2023	PS Planned sale	Eisele Jeffrey Chief Development Officer Officer	4,479 -8.6% 51.58 231,027 USD	4,479 -8.6%	51.58	231,027 USD
Jan. 19, 2023	Jan. 17, 2023	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 52.42 65,525 USD	1,250 -0.5%	52.42	65,525 USD
Jan. 10, 2023	Jan. 9, 2023	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 46.08 552,960 USD	12,000 -1.2%	46.08	552,960 USD
Jan. 9, 2023	Jan. 5, 2023	PS Planned sale	Grossi Federico Chief Medical Officer Officer	2,500 -2.6% 48.79 121,975 USD	2,500 -2.6%	48.79	121,975 USD
Jan. 5, 2023	Jan. 3, 2023	PS Planned sale	Dunlop A. Sinclair Non-Executive Director	500 -0.4% 50.70 25,350 USD	500 -0.4%	50.70	25,350 USD
Jan. 5, 2023	Jan. 3, 2023	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 50.70 253,500 USD	5,000 -10.4%	50.70	253,500 USD
Dec. 21, 2022	Dec. 19, 2022	PS Planned sale	Francois Cedric Chief Executive Officer Executive Director	24,449 -2.5% 52.07 1,273,052 USD	24,449 -2.5%	52.07	1,273,052 USD
Dec. 21, 2022	Dec. 19, 2022	PS Planned sale	Francois Cedric Chief Executive Officer Executive Director	3,751 -0.4% 51.97 194,931 USD	3,751 -0.4%	51.97	194,931 USD
Dec. 19, 2022	Dec. 15, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 52.35 65,438 USD	1,250 -0.5%	52.35	65,438 USD
Dec. 12, 2022	Dec. 8, 2022	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 47.50 570,000 USD	12,000 -1.2%	47.50	570,000 USD
Dec. 7, 2022	Dec. 5, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 50.38 251,900 USD	5,000 -10.4%	50.38	251,900 USD
Dec. 2, 2022	Dec. 1, 2022	PS Planned sale	Dunlop A. Sinclair Non-Executive Director	500 -0.4% 49.93 24,965 USD	500 -0.4%	49.93	24,965 USD
Dec. 2, 2022	Dec. 1, 2022	PS Planned sale	Grossi Federico Chief Medical Officer Officer	2,500 -2.5% 49.93 124,825 USD	2,500 -2.5%	49.93	124,825 USD
Nov. 17, 2022	Nov. 15, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 48.01 60,013 USD	1,250 -0.5%	48.01	60,013 USD
Nov. 10, 2022	Nov. 8, 2022	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 46.47 557,640 USD	12,000 -1.2%	46.47	557,640 USD
Nov. 7, 2022	Nov. 3, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 58.54 292,700 USD	5,000 -10.4%	58.54	292,700 USD
Nov. 3, 2022	Nov. 1, 2022	PS Planned sale	Grossi Federico Chief Medical Officer Officer	2,500 -2.4% 60.83 152,075 USD	2,500 -2.4%	60.83	152,075 USD
Nov. 3, 2022	Nov. 1, 2022	PS Planned sale	Dunlop A. Sinclair Non-Executive Director	500 -0.4% 60.83 30,415 USD	500 -0.4%	60.83	30,415 USD
Oct. 17, 2022	Oct. 14, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 59.31 74,138 USD	1,250 -0.5%	59.31	74,138 USD
Oct. 11, 2022	Oct. 10, 2022	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 57.50 690,000 USD	12,000 -1.2%	57.50	690,000 USD
Oct. 5, 2022	Oct. 3, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 66.69 333,450 USD	5,000 -10.4%	66.69	333,450 USD
Oct. 5, 2022	Oct. 3, 2022	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.4% 66.69 166,725 USD	2,500 -2.4%	66.69	166,725 USD
Sept. 16, 2022	Sept. 15, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 66.00 82,500 USD	1,250 -0.5%	66.00	82,500 USD
Sept. 12, 2022	Sept. 8, 2022	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 63.98 767,760 USD	12,000 -1.2%	63.98	767,760 USD
Sept. 8, 2022	Sept. 8, 2022	S Sale	Dunlop A. Sinclair Non-Executive Director	15,000 -5.9% 65.00 975,000 USD	15,000 -5.9%	65.00	975,000 USD
Sept. 7, 2022	Sept. 6, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 60.38 301,900 USD	5,000 -10.4%	60.38	301,900 USD
Sept. 2, 2022	Sept. 1, 2022	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.3% 60.30 150,750 USD	2,500 -2.3%	60.30	150,750 USD
Aug. 18, 2022	Aug. 17, 2022	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 69.50 347,500 USD	5,000 -14.6%	69.50	347,500 USD
Aug. 16, 2022	Aug. 15, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	12,500 -22.6% 69.00 862,500 USD	12,500 -22.6%	69.00	862,500 USD
Aug. 16, 2022	Aug. 15, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 67.21 84,013 USD	1,250 -0.5%	67.21	84,013 USD
Aug. 12, 2022	Aug. 11, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	12,500 -22.6% 67.00 837,500 USD	12,500 -22.6%	67.00	837,500 USD
Aug. 12, 2022	Aug. 11, 2022	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 67.00 335,000 USD	5,000 -14.6%	67.00	335,000 USD
Aug. 12, 2022	Aug. 11, 2022	S Sale	Dunlop A. Sinclair Non-Executive Director	30,000 -10.5% 65.63 1,968,900 USD	30,000 -10.5%	65.63	1,968,900 USD
Aug. 9, 2022	Aug. 8, 2022	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 64.50 322,500 USD	5,000 -14.6%	64.50	322,500 USD
Aug. 9, 2022	Aug. 8, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	12,500 -22.6% 65.00 812,500 USD	12,500 -22.6%	65.00	812,500 USD
Aug. 9, 2022	Aug. 8, 2022	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.3% 62.50 750,000 USD	12,000 -1.3%	62.50	750,000 USD
Aug. 8, 2022	Aug. 4, 2022	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 62.00 310,000 USD	5,000 -14.6%	62.00	310,000 USD
Aug. 8, 2022	Aug. 4, 2022	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -12.7% 59.50 297,500 USD	5,000 -12.7%	59.50	297,500 USD
Aug. 4, 2022	Aug. 3, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -11.7% 56.43 282,150 USD	5,000 -11.7%	56.43	282,150 USD
Aug. 2, 2022	Aug. 1, 2022	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.3% 55.99 139,975 USD	2,500 -2.3%	55.99	139,975 USD
July 28, 2022	July 27, 2022	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 57.00 285,000 USD	5,000 -14.6%	57.00	285,000 USD
July 21, 2022	July 19, 2022	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 56.42 282,100 USD	5,000 -14.6%	56.42	282,100 USD
July 18, 2022	July 15, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 46.33 57,913 USD	1,250 -0.5%	46.33	57,913 USD
July 12, 2022	July 11, 2022	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 48.42 242,100 USD	5,000 -10.4%	48.42	242,100 USD
July 12, 2022	July 8, 2022	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.3% 47.95 575,400 USD	12,000 -1.3%	47.95	575,400 USD
June 29, 2022	June 27, 2022	S Sale	Dunlop A. Sinclair Non-Executive Director	1,341 -50.0% 46.79 62,743 USD	1,341 -50.0%	46.79	62,743 USD
June 24, 2022	June 23, 2022	S Sale	Dunlop A. Sinclair Non-Executive Director	15,000 -5.0% 45.00 675,000 USD	15,000 -5.0%	45.00	675,000 USD
June 23, 2022	June 22, 2022	S Sale	Watson David O. General Counsel Officer	10,000 -8.0% 44.51 445,140 USD	10,000 -8.0%	44.51	445,140 USD
June 22, 2022	June 17, 2022	S Sale	Brown Victoria L. Program Team Lead Officer	2,698 -9.7% 45.00 121,410 USD	2,698 -9.7%	45.00	121,410 USD
June 21, 2022	June 16, 2022	S Sale	DeLong Mark Jeffrey Senior Vice President Officer	10,000 -25.5% 41.79 417,850 USD	10,000 -25.5%	41.79	417,850 USD
June 17, 2022	June 15, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 39.29 49,113 USD	1,250 -0.5%	39.29	49,113 USD
June 9, 2022	June 8, 2022	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.3% 44.09 529,080 USD	12,000 -1.3%	44.09	529,080 USD
June 2, 2022	June 1, 2022	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.2% 41.78 104,450 USD	2,500 -2.2%	41.78	104,450 USD
May 31, 2022	May 27, 2022	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	10,000 -19.9% 43.00 430,000 USD	10,000 -19.9%	43.00	430,000 USD
May 17, 2022	May 16, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 39.18 48,975 USD	1,250 -0.5%	39.18	48,975 USD
May 3, 2022	May 2, 2022	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.2% 43.56 108,900 USD	2,500 -2.2%	43.56	108,900 USD
May 2, 2022	April 29, 2022	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	4,000 -0.4% 44.43 177,720 USD	4,000 -0.4%	44.43	177,720 USD
April 27, 2022	April 25, 2022	PS Planned sale	Watson David O. General Counsel Officer	5,000 -3.8% 50.00 250,000 USD	5,000 -3.8%	50.00	250,000 USD
April 22, 2022	April 20, 2022	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	7,000 -19.7% 52.53 367,710 USD	7,000 -19.7%	52.53	367,710 USD
April 18, 2022	April 14, 2022	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 50.90 63,625 USD	1,250 -0.5%	50.90	63,625 USD
April 6, 2022	April 5, 2022	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	609 -1.2% 60.09 36,593 USD	609 -1.2%	60.09	36,593 USD

Get access to advanced features

Apellis Pharmaceuticals Inc (APLS) Track

Get access to advanced features

Stock chart

Transactions

Insider

Sort by

Apellis Pharmaceuticals Inc (APLS) ^Track